Literature DB >> 17653904

Invasive lobular breast cancer. Prognostic significance of histological malignancy grading.

Maj-Lis Møller Talman1, Maj-Britt Jensen, Fritz Rank.   

Abstract

Invasive lobular carcinoma (ILC) is the second most reported type of breast cancer in the Danish Breast Cancer Cooperative Group (DBCG). Several histological subtypes exist, with reports of different prognosis. The aim was to present the incidence of ILC in DBCG from 1977-2004, and evaluate tumours regarding diagnosis, histological subtype and grade, and relate to prognosis. Eight hundred and sixty tumours from patients with a diagnosis of ILC or ILC/non-ILC, who underwent breast cancer surgery in the period of 1990-1998, were evaluated. The impact of histological malignancy grade on disease-free survival and overall survival was analysed using a multivariate analysis adjusting for tumour size, hormone receptor status, axillary lymph node status and patient age. The incidence of pure ILC has risen from 5 to 12%, the ILC/non-ILC is constant at 2% of all reported breast cancers in DBCG. Most of the tumours were classical ILC grade II. The majority of the grade III tumours were among the non-classical subtypes, showing a statistically significant worse disease-free and overall survival compared to grade II, regardless of type. The prognosis was the same for grade I and grade II tumours. The number of positive axillary lymph nodes and hormone receptor negative tumours increased among grade III tumours. We conclude that histological malignancy grade has an independent significant impact on the prognosis of ILC, and it should be taken into consideration when planning the postoperative treatment in this group of patients.

Entities:  

Mesh:

Year:  2007        PMID: 17653904     DOI: 10.1080/02841860601137397

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  11 in total

1.  Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.

Authors:  Otto Metzger-Filho; Arlindo R Ferreira; Rinath Jeselsohn; William T Barry; Deborah A Dillon; Jane E Brock; Ines Vaz-Luis; Melissa E Hughes; Eric P Winer; Nancy U Lin
Journal:  Oncologist       Date:  2018-12-05

Review 2.  A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition.

Authors:  Hans-Peter Sinn; Hans Kreipe
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

3.  Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.

Authors:  Tong Wang; Yuanyuan Ma; Liang Wang; Hong Liu; Meixuan Chen; Ruifang Niu
Journal:  Tumour Biol       Date:  2015-03-25

4.  Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.

Authors:  Yu Zhang; Xiulan Luo; Min Chen; Libo Yang; Ting Lei; Tianjie Pu; Bing Wei; Hong Bu; Zhang Zhang
Journal:  Breast Cancer Res Treat       Date:  2022-06-06       Impact factor: 4.872

Review 5.  [Lobular neoplasms and invasive lobular breast cancer].

Authors:  H-P Sinn; B Helmchen; J Heil; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

Review 6.  [Invasive breast cancer: the current WHO classification].

Authors:  A Lebeau; M Kriegsmann; E Burandt; H-P Sinn
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

7.  Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor.

Authors:  Ulrik Narbe; Pär-Ola Bendahl; Dorthe Grabau; Lisa Rydén; Christian Ingvar; Mårten Fernö
Journal:  Springerplus       Date:  2014-02-06

8.  Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer.

Authors:  Inès J Beumer; Marion Persoon; Anke Witteveen; Christa Dreezen; Suet-Feung Chin; Stephen-John Sammut; Mireille Snel; Carlos Caldas; Sabine Linn; Laura J van 't Veer; Rene Bernards; Annuska M Glas
Journal:  Biomark Insights       Date:  2016-12-11

9.  Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.

Authors:  Monica J Engstrøm; Signe Opdahl; Lars J Vatten; Olav A Haugen; Anna M Bofin
Journal:  Histopathology       Date:  2014-12-22       Impact factor: 5.087

10.  Prognostic Significance of Substance P/Neurokinin 1 Receptor and Its Association with Hormonal Receptors in Breast Carcinoma.

Authors:  Riffat Mehboob; Syed Amir Gilani; Amber Hassan; Imrana Tanvir; Shaista Javaid; Sidra Khalid; Sana Hasan; Humaira Waseem; Ahmad Alwazzan; Miguel Munoz
Journal:  Biomed Res Int       Date:  2021-10-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.